HSA-2023-0092-V292

Type II variation for application HSA-2023-0092. Type II variation: Specification Change for Sacubitrivex — major revision

Variation Number
HSA-2023-0092-V292
Type
Type II
Application
HSA-2023-0092
Change
CHG-2021-0292
Status
In Progress
Fee
€21,827
Submitted
2024-01-15
Approved
—
Description

Type II variation: Specification Change for Sacubitrivex — major revision